Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound
Prophylactic vaccination of rhesus macaques with rhesus cytomegalovirus (RhCMV) vectors expressing simian immunodeficiency virus (SIV) antigens (RhCMV/SIV) elicits immune responses that stringently control hig...
-
Article
B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers
Fukazawa et al. report that SIV persists in follicular helper T cells in elite controller macaques, evading clearance by CD8+ T cells
-
Article
Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines
Live attenuated SIV vaccines protect nonhuman primates from infection with pathogenic wild-type SIV, but the crucial mechanisms have not been clear. In this issue, Louis Picker and colleagues show that protect...